The Beauty Health Company

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

The Beauty Health Company reports robust Q4 earnings and eyes international expansion opportunities

The Beauty Health Company delivered strong financial results in Q4 2022, showcasing consistent growth and profitability across regions.
Despite challenges like lower system ASP and heavy investments, the company's strategic initiatives and financial strength position it well for future growth.
Opportunities in international expansion, product portfolio enhancement, and market growth present avenues for sustained success in 2023 and beyond.
With a focus on operational efficiency, market adaptability, and category leadership, The Beauty Health Company remains poised for continued growth and profitability.

The Beauty Health Company (SKIN) reports robust Q1 performance and optimistic outlook for 2023

The Beauty Health Company (SKIN) showcased strong Q1 performance despite challenges, with a positive outlook for the year. The company's growth strategy, including the Cyndea system launch and boosters attachment rates, positions it well for future success.

Beauty Health Co. reports strong Q2, eyes global growth opportunities

The Beauty Health Company delivered strong Q2 results, reaffirming guidance despite challenges with Syndeo issues and gross margin pressure.
The company's focus on innovation, market resilience, and strategic investments positions it well for future growth and product expansion.
Opportunities in international markets, product enhancements, and margin improvement strategies present avenues for sustained performance and profitability.
Addressing challenges with Syndeo issues and gross margin pressure while leveraging market strengths and opportunities will be key to the company's continued success.

Beauty Health Co. addresses Syndeo challenges, focuses on growth

The Beauty Health Company is navigating challenges with Syndeo while focusing on customer-centric strategies and operational excellence under new leadership. Despite financial setbacks, the company aims for cost savings and growth opportunities through strategic transformation and reaccelerating Syndeo adoption in the U.S.

The Beauty Health Company reports solid Q4 performance and eyes growth in China market

The Beauty Health Company's Q4 2023 performance reflects revenue growth driven by APAC and EMEA, with operational efficiency and cost savings initiatives.
Strategic strengths include a strong cash position, inventory optimization efforts, and growth opportunities in the Chinese market.
Challenges include quality control issues, revenue declines in certain regions, and short-term financial pressures to be managed effectively.
Opportunities lie in expanding product offerings in China, improving gross margins, and addressing quality concerns to drive sustainable growth.

The Beauty Health Company (SKIN) surpasses Q1 targets, eyes growth

SKIN's Q1 performance exceeded expectations, with strong revenue and EBITDA figures, driven by consumables growth and operational improvements.
While facing challenges in equipment sales and product costs, SKIN's focus on excellence and growth opportunities position the company well for the future.
Analyst inquiries highlighted areas for improvement, but Marla Beck's confidence in growth avenues underscores a positive outlook for SKIN.

The Beauty Health Company (SKIN) exceeds Q3 revenue guidance, navigates market challenges

SKIN's Q3 2024 performance showcased revenue above guidance, profitability, and strategic advancements in sales, operations, and innovation.
While facing revenue declines and market challenges, SKIN's focus on profitability, margin expansion, and operational effectiveness signals a commitment to long-term success.
Navigating challenges with a proactive approach and seizing growth opportunities can position SKIN for sustained success and market resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacialTM, today announced financial results for the third quarter ended September 30, 2021. Brent Saunders, BeautyHealth's Executive Chairman, stated: “We are very pleased with our results this quarter, as well as the strength of our year-to-date performance. Our sales and adjusted EBITDA continu

The Beauty Health Company Reports Record Third Quarter 2021 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced the results of the completed redemption (the “Redemption”) of all of its outstanding public warrants (the “Public Warrants”) to purchase shares of the Company's Class A common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agree

The Beauty Health Company Announces the Results of the Completed Redemption of All Outstanding Public Warrants

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced that as of October 18, 2021, approximately 6.86 million of the total approximately 15.33 million warrants (“Public Warrants”) to purchase shares of the Company's Class A common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agre

The Beauty Health Company Reminds Investors of Redemption of Public Warrants

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial™, today announced that it will report third quarter 2021 financial results after market close on Tuesday, November 9, 2021. The Company will host a conference call at 4:30 p.m. Eastern Time on Tuesday, November 9, 2021, to discuss the financial results. Investors and analysts interested in

The Beauty Health Company to Report Third Quarter 2021 Financial Results on November 9, 2021

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company's Class A common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated September 29, 2020, by and b

The Beauty Health Company Announces Redemption of All Outstanding Warrants

LONG BEACH, Calif.--(BUSINESS WIRE)--HydraFacial, a BeautyHealth Company, announced their first collaboration with Epicutis, a luxury skincare line.

HydraFacial, A BeautyHealth Company, Launches New Neck & Décolleté Booster with Epicutis

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator leading the charge with its flagship brand HydraFacial, today announced Clint Carnell, Chief Executive Officer, and Liyuan Woo, Chief Financial Officer, will participate virtually in the following upcoming investor conferences: Cowen 2nd Annual Health, Wellness & Beauty Summit Presentation Date: Monday, September 13, 2021, 5:00 p.m. ET Raymond James Virtua

The Beauty Health Company to Present at Upcoming September Investor Conferences

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN) today announced the pricing of its offering of $650,000,000 aggregate principal amount of 1.25% convertible senior notes due 2026 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced of

The Beauty Health Company Prices Upsized $650 Million Convertible Senior Notes Offering

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). BeautyHealth also expects to grant th

The Beauty Health Company Announces Proposed Convertible Senior Notes Offering

Beauty Health's fiscal 2021 second quarter results were a strong beat on analyst estimates. Operational momentum during the quarter led the company to raise its revenue guidance for the year.

Beauty Health: Q2 Results Support The Bull Thesis

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (“BeautyHealth” or the “Company”) (NASDAQ: SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced the appointment of Indra Pamamull as President of APAC and the promotion of Mingo Ku to Chief Commercial Officer in APAC. With over two decades in beauty across skin care, fragrance and color cosmetics, Mrs. Pamamull has executed successful brand strategies to deliver in

The Beauty Health Company Reiterates International Expansion Plans with Announcement of Key Leadership Appointments in APAC

The stock price of Beauty Health Co (NASDAQ: SKIN) increased by over 6% pre-market. This is why it happened.

SKIN Stock Price Increases Over 6% Pre-Market: Why It Happened

Beauty Health Co (NASDAQ: SKIN) reported second-quarter FY21 sales growth of 371% year-on-year, to $66.51 million. Net sales improved 57.1% from Q2 2019.

Beauty Health Stock Gains On Strong Q2 Earnings, Raised FY21 Guidance

The Beauty Health Company (SKIN) CEO Clint Carnell on Q2 2021 Results - Earnings Call Transcript

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced financial results for the second quarter ended June 30, 2021. Clint Carnell, BeautyHealth's CEO, stated: “Our second quarter results reflect exceptional performance in both sales and adjusted EBITDA. We achieved strong sales in our Delivery Systems, and trends in our Consu

The Beauty Health Company Reports Record Second Quarter 2021 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (“BeautyHealth” or the “Company”) (NASDAQ: SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced the appointments of Ben Baum as Chief Experience Officer, effective immediately, and Stephan Becker, as President of EMEA, effective October 1, 2021. Ben Baum Joins as Chief Experience Officer Mr. Baum has over two decades of experience as a senior operating executive in

The Beauty Health Company Announces Hiring of Two Senior Executives to Support Growth

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator leading the charge with its flagship brand HydraFacial, today announced that it will report second quarter 2021 financial results after market close on Tuesday, August 10, 2021. The Company will host a conference call at 4:30 p.m. Eastern Time on Tuesday, August 10, 2021 to discuss the financial results. Investors and analysts interested in participating in th

The Beauty Health Company to Report Second Quarter 2021 Financial Results on August 10, 2021

Beauty Health is poised for years of growth in the growing global beauty health market. The company is building a platform to add other beauty products and treatments to the global platform and distribution system.

Beauty Health: Beautiful Growth Story

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator leading the charge with its flagship brand HydraFacial, today announced that it has joined the broad-market Russell 3000® and the Russell 2000® Indexes, effective today, Monday, June 28, 2021 at market open, based on the final index membership lists, which are available on the FTSE Russell website. Annual Russell indexes reconstitution captures the 4,000 large

The Beauty Health Company Joins Russell 3000® and 2000® Indexes

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (“BeautyHealth” or the “Company”) (NASDAQ: SKIN), parent entity of The HydraFacial® Company (“HydraFacial”), a global category-creating beauty health company, today announced the expansion of its global footprint, with the pending or completed acquisitions of four international, third-party distributors for HydraFacial. The total purchase price for the four distributors will be approximately $35 million, consisting of approximately

The Beauty Health Company Expands International Direct Market Presence

LONG BEACH, Calif.--(BUSINESS WIRE)-- #GLOWvolution--HydraFacial, a BeautyHealth company (NASDAQ:SKIN), launched the #GLOWvolution tour this past weekend, a coast-to-coast US tour, welcoming new faces to The HydraFacial Nation. The first stop took place June 4th – 7th in Miami, FL and introduced hundreds of consumers to the benefits of the fan-favorite treatment. Over the course of four months, the #GLOWvolution Tour will offer complimentary HydraFacial treatments to consumers. A huge, tricked-out, super-brand

HydraFacial, A BeautyHealth Company, Launches #GLOWvolution

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator leading the charge with its flagship brand HydraFacial, today announced that senior management will participate virtually in the following upcoming investor conferences: Goldman Sachs Annual Global Healthcare Conference Presentation Date: Thursday, June 10, 2021, 3:00 p.m. ET Jefferies Virtual Consumer Conference Presentation Date: Tuesday, June 22, 2021, 4:25

The Beauty Health Company to Present at Upcoming June Investor Conferences

The Beauty Health Company is the owner of HydraFacial, a category-creating, non-invasive skin care treatment that leaves you with a glowing face in just 30 minutes. HydraFacial has over 17,000 delivery systems in over 87 countries providing millions of treatments each year.

The Beauty Health Company: A Category-Creator In The Growing Skin Care Industry

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), formerly known as Vesper Healthcare Acquisition Corp. (the “Company”), today announced it received a notice on May 19, 2021 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the “Quarterly Report”), the Company no longer complies with the continued l

The Beauty Health Company Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report

The Beauty Health Company's (SKIN) CEO Clint Carnell on Q1 2021 Results - Earnings Call Transcript

News for The Beauty Health Company Stock (SKIN)